Lanzamiento Enero 2027

Ensayo controlado aleatorizado2023Financiación no declaradaAcceso abierto

A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study

Majeed M, Nagabhushanam K, Mundkur L

Medicine · 27 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2023-10-13 · Medicine (Baltimore) · vol. 102 · número 41 · pág. e35521
Editorial
Wolters Kluwer
Citado
44 citas · más que el 99% de estudios similares · 13.8× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
55 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Phytochemicals and Medicinal Plants · Piperaceae Chemical and Biological Studies · Medicinal Plants and Neuroprotection
Palabras clave
Medicine, Placebo, Piperine, Anxiety, Pittsburgh Sleep Quality Index, Cambridge Neuropsychological Test Automated Battery, Randomized controlled trial, Internal medicine, Pharmacology, Psychiatry, Insomnia
MeSH
humans, serotonin, alkaloids, piperidines, hydrocortisone, plant extracts, double-blind method, anxiety, anxiety disorders, quality of life, adult, india, benzodioxoles, polyunsaturated alkamides, withanolides, covid-19

3 autores

  • Muhammed A. Majeed🇺🇸Sabin Vaccine Institute
  • Kalyanam Nagabhushanam🇺🇸Sabin Vaccine Institute
  • Lakshmi Mundkur · autor de correspondencia

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

The coronavirus disease-2019 (COVID-19) pandemic has resulted in a surge in stress, anxiety, and depression worldwide. Ashwagandha, an ayurvedic adaptogen has been traditionally used to manage stress, anxiety, and general well-being.

Objective

We assessed the effect of Ashwagandha root extract (ARE-500 mg) standardized for 2.5% withanolides as per USP protocol with piperine (5 mg of 95% piperine) once daily for 60 days (12.5 mg withanolides/day) to alleviate stress and anxiety in healthy individuals with mild to moderate symptoms.

Methods

A randomized, double-blind, placebo-controlled study was conducted for 60 days using ARE (n = 27) and placebo (n = 27) once daily at night at Narayana Institute of Cardiac Sciences, Bangalore, and Vijaya Super Specialty Hospital, Nellore, in India. The objectives of this study were to assess an improvement in perceived stress scale (PSS), generalized anxiety disorder (GAD-7), quality of life (QOL), cognitive scores in the Cambridge Neuropsychological Test Automated Battery (CANTAB), changes in salivary cortisol, urinary serotonin, dopamine, serum levels of nitric oxide (NO), glutathione (GSH) and malondialdehyde (MDA) from baseline to end of the study. Safety was evaluated by laboratory parameters, and by monitoring any incidence of adverse events.

Results

54 individuals were randomized and 50 of them completed the study. The PSS, GAD-7, and QOL scores improved significantly in all the participants taking ARE compared to the placebo. The CANTAB analysis revealed a significant improvement in multitasking, concentration, and decision taking time in ARE compared to placebo. ARE was also associated with a greater reduction in the morning salivary cortisol and an increase in urinary serotonin compared to placebo. Serum levels of NO, GSH, and MDA were not significantly different. Biochemical and hematological parameters remained in the normal range in all participants and ARE was well tolerated during the study.

Conclusion

The results of the study suggest that ARE with 2.5% withanolides can effectively improve stress and anxiety by reducing cortisol and increasing serotonin in healthy individuals with mild to moderate symptoms.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.